Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies.
Younhee ParkKi Ho HongSu Kyung LeeJungwon HyunEun Jee OhJaehyeon LeeHyuk Min LeeSang Hoon SongSeung-Jung KeeGye Cheol KwonSu Hwan KimHyeon-Nam DoAh-Ra KimJune-Woo LeeSung Soon KimHyun Soo KimPublished in: Annals of laboratory medicine (2021)
The prevalence of COVID-19 in Korea is considered to be exceptionally low at present; thus, we recommend using a combination of two or more SARS-CoV-2 antibody assays rather than a single assay. These results could help select SARS-CoV-2 antibody assays for COVID-19 seroprevalence studies in Korea.